A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients

被引:25
作者
Sing, GK
Ladhams, A
Arnold, S
Parmar, H
Chen, X
Cooper, J
Butterworth, L
Stuart, K
D'Arcy, D
Cooksley, WGE
机构
[1] Royal Brisbane Hosp, Res Ctr, Clin Res Ctr, Herston, Qld, Australia
[2] Roche Prod Ltd, Global Drug Dev, Welwyn Garden City AL7 3AY, Herts, England
[3] St Jude Childrens Res Hosp, Dept Virol & Mol Biol, Memphis, TN 38105 USA
[4] Queensland Inst Med Res, Bancroft Ctr, Herston, Qld 4006, Australia
关键词
chronic hepatitis B; cytotoxic T-cell; hepatitis B virus; interleukin-12; precursor frequency analysis;
D O I
10.1046/j.1365-2893.2001.00260.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Individuals with acute hepatitis B virus (HBV) infection characteristically mount a strong, multispecific cytotoxic T lymphocyte (CTL) response that is effective in eradicating virus. In contrast, this response in chronic carriers is usually weak or undetectable. Since it is generally acknowledged that HBV pathogenesis is immune-mediated, the occurrence of episodes of active liver disease in many carriers suggests that these individuals can mount active CTL responses to HBV. To see whether the detection of circulating CTLs is related to these flare episodes, we have determined the CTL precursor (CTLp) frequencies to HLA-A2-restricted viral peptides in seven patients over a 12-24-month period of their disease. Limiting dilution analyses (LDA) were performed longitudinally to five epitopes comprising the viral capsid (HBc), envelope (HBs) and polymerase (pol) proteins. Assays were performed against a mixture of peptides, or against each individual peptide, to measure overall CTL activity and the multispecificity of the responses, respectively. Since two of the patients were treated with recombinant human interleukin-12 (rHuIL-12) at the time, with one individual achieving complete disease remission a year later after being treated with interferon-alpha, we were also able to examine the effects of these cytokines on HBV cytotoxicity. Our results indicate that weak but detectable CTL responses do occur in chronic carriers which are generally associated with disease flares, although CTLps were also seen occasionally during minimal disease activity. The range of specificities varied between individuals and within each individual during the course of the disease. Finally, we also provide evidence that CTL reactivity is stimulated following treatment with certain cytokines, but is dependent on the time of administration.
引用
收藏
页码:19 / 29
页数:11
相关论文
共 18 条
  • [1] CYTOTOXIC T-LYMPHOCYTE RESPONSE TO A WILD-TYPE HEPATITIS-B VIRUS EPITOPE IN PATIENTS CHRONICALLY INFECTED BY VARIANT VIRUSES CARRYING SUBSTITUTIONS WITHIN THE EPITOPE
    BERTOLETTI, A
    COSTANZO, A
    CHISARI, FV
    LEVRERO, M
    ARTINI, M
    SETTE, A
    PENNA, A
    GIUBERTI, T
    FIACCADORI, F
    FERRARI, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) : 933 - 943
  • [2] CARRIER-MEDIATED UPTAKE AND PRESENTATION OF A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED PEPTIDE
    BRANDER, C
    WYSSCORAY, T
    MAURI, D
    BETTENS, F
    PICHLER, WJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) : 3217 - 3223
  • [3] T-CELL RECEPTOR REPERTOIRE FOR A VIRAL EPITOPE IN HUMANS IS DIVERSIFIED BY TOLERANCE TO A BACKGROUND MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN
    BURROWS, SR
    SILINS, SL
    MOSS, DJ
    KHANNA, R
    MISKO, IS
    ARGAET, VP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 1703 - 1715
  • [4] CARMAN WF, 1989, LANCET, V2, P588
  • [5] A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
    Carreño, V
    Zeuzem, S
    Hopf, U
    Marcellin, P
    Cooksley, WGE
    Fevery, J
    Diago, M
    Reddy, R
    Peters, M
    Rittweger, K
    Rakhit, A
    Pardo, M
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 (02) : 317 - 324
  • [6] Interleukin-12 inhibits hepatitis B virus replication in transgenic mice
    Cavanaugh, VJ
    Guidotti, LG
    Chisari, FV
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 3236 - 3243
  • [7] HEPATITIS-B VIRUS IMMUNOPATHOGENESIS
    CHISARI, FV
    FERRARI, C
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 : 29 - 60
  • [8] Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus
    deCamposLima, PO
    Levitsky, V
    Imreh, MP
    Gavioli, R
    Masucci, MG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 83 - 89
  • [9] FERRARI C, 1990, J IMMUNOL, V145, P3442
  • [10] INTERLEUKIN-12
    GERMANN, T
    RUDE, E
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 108 (02) : 103 - 112